Genetic effects of radiotherapy for childhood cancer: gonadal dose reconstruction.

PURPOSE To estimate the doses of radiation to organs of interest during treatment of childhood cancer for use in an epidemiologic study of possible heritable diseases, including birth defects, chromosomal abnormalities, cancer, stillbirth, and neonatal and premature death. METHODS AND MATERIALS The study population was composed of more than 25,000 patients with cancer in Denmark and the United States who were survivors of childhood cancer and subsequently had nearly 6,500 children of their own. Radiation therapy records were sought for the survivors who parented offspring who had adverse pregnancy outcomes (>300 offspring), and for a sample of all survivors in a case-cohort design. The records were imaged and centrally abstracted. Water phantom measurements were made to estimate doses for a wide range of treatments. Mathematical phantoms were used to apply measured results to estimate doses to ovaries, uterus, testes, and pituitary for patients ranging in age from newborn to 25 years. Gonadal shielding, ovarian pinning (oophoropexy), and field blocking were taken into account. RESULTS Testicular radiation doses ranged from <1 to 700 cGy (median, 7 cGy) and ovarian doses from <1 to >2,500 cGy (median, 13 cGy). Ten percent of the records were incomplete, but sufficient data were available for broad characterizations of gonadal dose. More than 49% of the gonadal doses were >10 cGy and 16% were >100 cGy. CONCLUSIONS Sufficient radiation therapy data exist as far back as 1943 to enable computation of gonadal doses administered for curative therapy for childhood cancer. The range of gonadal doses is broad, and for many cancer survivors, is high and just below the threshold for infertility. Accordingly, the epidemiologic study has >90% power to detect a 1.3-fold risk of an adverse pregnancy outcome associated with radiation exposure to the gonads. This study should provide important information on the genetic consequences of radiation exposure to humans.

[1]  S. C. Sharma,et al.  Measurement and calculation of ovary and fetus dose in extended field radiotherapy for 10 MV x rays. , 1981, International journal of radiation oncology, biology, physics.

[2]  R. Smith,et al.  Pregnancy outcomes in childhood cancer survivors: Probable effects of abdominal irradiation , 1989, International journal of cancer.

[3]  H. B. Marsden,et al.  Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. , 1996, Journal of the National Cancer Institute.

[4]  P. François,et al.  A mathematical child phantom for the calculation of dose to the organs at risk. , 1988, Medical physics.

[5]  D. Green,et al.  Birth defects and childhood cancer in offspring of survivors of childhood cancer. , 1997, Archives of pediatrics & adolescent medicine.

[6]  S. Mutic,et al.  Peripheral dose distributions for a linear accelerator equipped with a secondary multileaf collimator and universal wedge , 2002, Journal of applied clinical medical physics.

[7]  P. Rubin,et al.  Scattered radiation dosage as a function of x-ray energy. , 1974, Radiology.

[8]  K. Kase,et al.  Measurements of dose from secondary radiation outside a treatment field. , 1983, International journal of radiation oncology, biology, physics.

[9]  S. Donaldson,et al.  Pregnancy following oophoropexy and total nodal irradiation in women with Hodgkin's disease. , 1977, Cancer.

[10]  D. Green,et al.  Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. , 2002, American journal of obstetrics and gynecology.

[11]  T. Murray.  Cancer incidence after retinoblastoma: radiation dose and sarcoma risk. , 1998, Survey of ophthalmology.

[12]  G. M. Roberts,et al.  Basic Atlas of Sectional Anatomy: With Correlated Imaging , 1998 .

[13]  L. Strong,et al.  Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. , 1998, American journal of human genetics.

[14]  M. Aitkin,et al.  Stillbirths among offspring of male radiation workers at Sellafield Nuclear Reprocessing Plant , 1999, The Lancet.

[15]  S. Horning,et al.  Female Reproductive Potential after Treatment for Hodgkin's Disease , 1981, New England Journal of Medicine.

[16]  S. Kieffer,et al.  An Atlas of Cross-Sectional Anatomy: Computed Tomography, Ultrasound, Radiography, Gross Anatomy , 1979 .

[17]  H. Bierhuizen,et al.  Comparison of measured and calculated peripheral doses in patients undergoing radiation therapy. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  A. C. Eycleshymer,et al.  A cross-section anatomy , 1970 .

[19]  J. Neel,et al.  Genetic studies at the Atomic Bomb Casualty Commission-Radiation Effects Research Foundation: 1946-1997. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  V. Beral,et al.  Fetal death and congenital malformation in babies born to nuclear industry employees: report from the nuclear industry family study , 2000, The Lancet.

[21]  G. Darlington,et al.  Pregnancy outcomes in females after treatment for childhood cancer. , 2000, Epidemiology.

[22]  G. E. Holmes,et al.  Pregnancy outcome of patients treated for Hodgkin's disease. A controlled study , 1978, Cancer.

[23]  D. Gabriel,et al.  Oophoropexy and the management of Hodgkin's disease. A reevaluation of the risks and benefits. , 1986, Archives of surgery.

[24]  Robert J. Shalek,et al.  Fetal Dose from Radiotherapy with Photon Beams , 1995 .

[25]  B. Fraass,et al.  Peripheral dose from megavolt beams. , 1983, Medical physics.

[26]  P. François,et al.  Calculation of the dose delivered to organs outside the radiation beams. , 1988, Medical physics.

[27]  M. Little,et al.  A comparison of the risk of stillbirth associated with paternal pre-conception irradiation in the Sellafield workforce with that of stillbirth and untoward pregnancy outcome among Japanese atomic bomb survivors , 1999, Journal of radiological protection : official journal of the Society for Radiological Protection.

[28]  C R Blackwell,et al.  Fetal dose from radiotherapy with photon beams: report of AAPM Radiation Therapy Committee Task Group No. 36. , 1995, Medical physics.

[29]  L. Specht,et al.  Ovarian function in young women in long-term remission after treatment for Hodgkin's disease stage I or II. , 2009, Scandinavian journal of haematology.

[30]  J. Byrne.  Long-term genetic and reproductive effects of ionizing radiation and chemotherapeutic agents on cancer patients and their offspring. , 1999, Teratology.

[31]  Bernice B. Capusten.  Basic Atlas of Sectional Anatomy with Correlated Imaging. 3rd ed , 1998 .

[32]  L. Wagner,et al.  Erratum: “Fetal dose from radiotherapy with photon beams: Report of AAPM Radiation Therapy Committee Task Group No. 36” [Med. Phys. 22. 63-82 (1995)] , 1995 .

[33]  J. Boice,et al.  Stillbirths and male irradiation. , 2000, Journal of radiological protection : official journal of the Society for Radiological Protection.

[34]  L. Strong,et al.  CANCER IN OFFSPRING OF LONG-TERM SURVIVORS OF CHILDHOOD AND ADOLESCENT CANCER , 1987, The Lancet.

[35]  K. Kase,et al.  Measurements of dose from secondary radiation outside a treatment field: effects of wedges and blocks. , 1985, International journal of radiation oncology, biology, physics.

[36]  B. McParland.  Peripheral doses of two linear accelerators employing universal wedges. , 1990, The British journal of radiology.

[37]  Alicia Samuels,et al.  Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.

[38]  J. Blatt.  Pregnancy outcome in long-term survivors of childhood cancer. , 1999, Medical and pediatric oncology.

[39]  N. Breslow,et al.  Pregnancy outcome after treatment for Wilms tumor: a report from the National Wilms Tumor Study Group. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  S. Donaldson,et al.  Pregnancy following oophoropexy and total nodal irradiation in women with Hodgkinapos;s disease , 1976, Cancer.

[41]  P. V. D. Giessen.  A simple and generally applicable method to estimate the peripheral dose in radiation teletherapy with high energy x-rays or gamma radiation. , 1996 .

[42]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[43]  B. Fraass,et al.  Peripheral dose to the testes: the design and clinical use of a practical and effective gonadal shield. , 1985, International journal of radiation oncology, biology, physics.

[44]  M. Stovall,et al.  Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. , 2003, JAMA.

[45]  H. Averette,et al.  Effects of cancer chemotherapy on gonadal function and reproductivecapacity , 1990, CA: a cancer journal for clinicians.

[46]  John D Potter,et al.  Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. , 2002, Medical and pediatric oncology.

[47]  J. Higginson,et al.  Abdominal irradiation in childhood; the potential for pregnancy , 1992, British journal of obstetrics and gynaecology.

[48]  M. Stovall,et al.  Tissue doses from radiotherapy of cancer of the uterine cervix. , 1989, Medical physics.

[49]  W E Barlow,et al.  Analysis of case-cohort designs. , 1999, Journal of clinical epidemiology.

[50]  J. Olsen,et al.  GENETIC EFFECTS OF RADIOTHERAPY FOR CHILDHOOD CANCER , 2003, Health physics.

[51]  J. Fraumeni,et al.  Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. , 1997, JAMA.

[52]  S Wacholder,et al.  Practical considerations in choosing between the case-cohort and nested case-control designs. , 1991, Epidemiology.

[53]  M. Peckham,et al.  Reproductive and endocrine function in patients with Hodgkin's disease: effects of oophoropexy and irradiation. , 1976, British Journal of Cancer.

[54]  E Glattre,et al.  Risk of cancer among offspring of childhood-cancer survivors. Association of the Nordic Cancer Registries and the Nordic Society of Paediatric Haematology and Oncology. , 1998, The New England journal of medicine.

[55]  P. van der Giessen.  A simple and generally applicable method to estimate the peripheral dose in radiation teletherapy with high energy x-rays or gamma radiation. , 1996, International journal of radiation oncology, biology, physics.

[56]  W. Shipley,et al.  Reduction of the scatter dose to the testicle outside the radiation treatment fields. , 1982, International journal of radiation oncology, biology, physics.

[57]  M. Cristy,et al.  Active bone marrow distribution as a function of age in humans. , 1981, Physics in medicine and biology.

[58]  Murray Boles,et al.  Central axis depth dose data for use in radiotherapy. A survey of depth doses and related data measured in water or equivalent media. , 1972, British journal of radiology. Supplement.

[59]  A. Steinfeld.  The Children of Atomic Bomb Survivors , 1993 .

[60]  R. Taylor,et al.  Dose levels outside radiotherapy beams. , 1983, The British journal of radiology.

[61]  F. Marshall.  Pregnancy outcome after treatment for Wilms tumor: a report from the National Wilms Tumor Study Group. , 2003, The Journal of urology.

[62]  A. Niroomand-rad,et al.  Measured dose to ovaries and testes from Hodgkin's fields and determination of genetically significant dose. , 1993, International journal of radiation oncology, biology, physics.